Marksans Pharma Announcements
Marksans Pharma Limited''s wholly owned subsidiary Relonchem Limited receives Marketing Authorisation for it products from UK MHRA.
15 Oct, 2025 | 01:54pm • Source: BSE
Marksans Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
13 Oct, 2025 | 12:33pm • Source: NSE
Certificate received from RTA under 74(5) for the quarter and half year ended September 30, 2025.
13 Oct, 2025 | 11:33am • Source: BSE
CARE Ratings Limited have upgraded and reaffirmed outlook for the Long term and Short term Bank Facilities
08 Oct, 2025 | 10:53am • Source: BSE
100 days campaign notification for all shareholders
06 Oct, 2025 | 03:03pm • Source: BSE
Intimation for closure of trading window for the quarter and half year ended September 2025.
25 Sep, 2025 | 02:19pm • Source: BSE
The Nomination and Remuneration Committee (designated Compensation Committee) considered and approved the grant of 4,00,000 option to eligible employees.
24 Sep, 2025 | 04:51pm • Source: BSE
Marksans Pharma Ltd''s subsidiary Relonchem Limited in UK receives marketing authorisation for its products from UK MHRA
23 Sep, 2025 | 02:10pm • Source: BSE
Investor / Analyst meet - Pharma & Healthcare Conference - DAM Capital
22 Sep, 2025 | 05:14pm • Source: BSE
100 days campaign for KYC and other related updations and shareholder engagement to prevent transfer of unclaimed dividends to IEPF
16 Sep, 2025 | 12:05pm • Source: BSE
IEPF Newspaper Publication
25 Aug, 2025 | 03:21pm • Source: BSE
Please find the advertisement published by the company in regards to the campaign.
25 Aug, 2025 | 03:19pm • Source: BSE
Please find attached publication for Saksham Niveshak Campaign.
25 Aug, 2025 | 02:50pm • Source: BSE
Marksans Pharma Limited has informed the Exchange about Transcript
19 Aug, 2025 | 11:04am • Source: NSE
Earnings call transcript for Q1 FY 26.
19 Aug, 2025 | 10:52am • Source: BSE
Marksans Pharma Limited has informed the Exchange regarding a press release dated August 18, 2025, titled "Marksans Pharma Limited s wholly owned subsidiary in UK,...
18 Aug, 2025 | 12:34pm • Source: NSE
Marksans Pharma Limited wholly owned subsidiary in UK, Relonchem Limited receives marketing authorization for its products.
18 Aug, 2025 | 12:17pm • Source: BSE
Analyst/ Investor meet audio recording
13 Aug, 2025 | 07:14pm • Source: BSE
Attached is the newspaper publication of the financial results for the quarter ended June 30, 2025.
13 Aug, 2025 | 11:27am • Source: BSE
The Board in its meeting considered and adopted Financial Results for the Quarter ended June 30, 2025.
12 Aug, 2025 | 01:46pm • Source: BSE